3rd Quarter - Report

CGCN GROUP, LLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to innovative non-opioid medicines.

LobbyistCovered position, as disclosed
SAM GEDULDIG —
JILL HAMAKER —
MARTHA BEATRICE MILLER Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022.

Contacted: White House Office; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Medicare/Medicaid MMM

Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 1227; Alternatives to PAIN, S. 475.

LobbyistCovered position, as disclosed
SAM GEDULDIG —
JILL HAMAKER —
MARTHA BEATRICE MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1227 (119th), S. 475 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.